Use of 11C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma: Clinical article

Journal of Neurosurgery

Volumn 116, Issue 4, 2012, Pages 835-842

  Chiba, Yasuyoshi ^a   Kinoshita, Manabu ^a   Okita, Yoshiko ^a   Tsuboi, Akihiro ^a   Isohashi, Kayako ^a   Kagawa, Naoki ^a   Fujimoto, Yasunori ^a   Oji, Yusuke ^a   Oka, Yoshihiro ^a   Shimosegawa, Eku ^a   Morita, Satoshi ^b   Hatazawa, Jun ^a   Sugiyama, Haruo ^a   Hashimoto, Naoya ^a   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11C methionine PET; Glioma; Oncology; Parametric response map; WT1 immunotherapy

Indexed keywords

GADOLINIUM PENTETATE; METHIONINE C 11; WT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DRUG TRANSPORT; FEMALE; GLIOMA; HUMAN; IMMUNOTHERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; BRAIN NEOPLASMS; CANCER VACCINES; CARBON RADIOISOTOPES; CELL SURVIVAL; FEMALE; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRADERMAL; MAGNETIC RESONANCE IMAGING; MALE; MANNITOL; METHIONINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLEIC ACIDS; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; TUMOR BURDEN; WT1 PROTEINS; YOUNG ADULT;

EID: 84859360516     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.12.JNS111255     Document Type: Article

References (19)

1. Berger G, Maziere M, Knipper R, Prenant C, Comar D: Automated synthesis of 11C-labelled radiopharmaceuticals: imipramine, chlorpromazine, nicotine and methionine. Int J Appl Radiat Isot 30:393-399, 1979 (Pubitemid 9238660)
2. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ: Clinical features, mechanisms, and management of pseudo-progression in malignant gliomas. Lancet Oncol 9:453-461, 2008 (Pubitemid 351597795)
3. Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, et al: Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 7:68-74, 1997 (Pubitemid 28365640)
4. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al: Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95: 746-750, 2001 (Pubitemid 33043345)
5. Galanis E, Buckner JC, Maurer MJ, Sykora R, Castillo R, Ballman KV, et al: Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro Oncol 8:156-165, 2006 (Pubitemid 46542660)
6. Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, et al: The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 15:572-576, 2009
7. Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA, et al: Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res 17:7451-4760, 2011
8. Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK, et al: Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102:16759-16764, 2005 (Pubitemid 41688850)
9. Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, et al: Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 108:963-971, 2008 (Pubitemid 351656845)
10. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432-445, 2001 (Pubitemid 32207394)
11. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, et al: Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507, 2005 (Pubitemid 43186642)
12. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al: Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90:194-204, 1999 (Pubitemid 29112320)
13. Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, et al: Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors. Cancer Sci 95:822-827, 2004 (Pubitemid 39545589)
14. Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H, et al: Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A 101:13885-13890, 2004 (Pubitemid 39298502)
15. Okita Y, Kinoshita M, Goto T, Kagawa N, Kishima H, Shimosegawa E, et al: (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage 49:2977-2982, 2010
16. Shah GD, Kesari S, Xu R, Batchelor TT, O'Neill AM, Hochberg FH, et al: Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 8:38-46, 2006 (Pubitemid 43154449)
17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
18. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
19. Veninga T, Huisman H, van der Maazen RW, Huizenga H: Clinical validation of the normalized mutual information method for registration of CT and MR images in radiotherapy of brain tumors. J Appl Clin Med Phys 5:66-79, 2004